Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioFCF Payout RatioInventory AverageInvested Capital

Conmed (CNMD) Return on Sales (2016 - 2021)

Historic Return on Sales for Conmed (CNMD) over the last 12 years, with Q3 2021 value amounting to 0.54%.

  • Conmed's Return on Sales fell 300.0% to 0.54% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.54%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.03% for FY2025, which is 700.0% down from last year.
  • As of Q3 2021, Conmed's Return on Sales stood at 0.54%, which was down 300.0% from 0.55% recorded in Q2 2021.
  • Conmed's Return on Sales' 5-year high stood at 0.56% during Q3 2020, with a 5-year trough of 0.46% in Q2 2020.
  • In the last 5 years, Conmed's Return on Sales had a median value of 0.54% in 2018 and averaged 0.54%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -900bps in 2020, then skyrocketed by 900bps in 2021.
  • Over the past 5 years, Conmed's Return on Sales (Quarter) stood at 0.56% in 2017, then decreased by -2bps to 0.55% in 2018, then decreased by -2bps to 0.54% in 2019, then fell by 0bps to 0.54% in 2020, then changed by 0bps to 0.54% in 2021.
  • Its Return on Sales was 0.54% in Q3 2021, compared to 0.55% in Q2 2021 and 0.53% in Q1 2021.